Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. Lidia Tajber

Associate Professor (Pharmacy)
25/6/7 WESTLAND ROW


Lidia is currently employed as an Associate Professor in Pharmaceutics and Pharmaceutical Technology in the School of Pharmacy and Pharmaceutical Sciences. She first gained M. Pharm. degree from Medical University of Silesia, Katowice, Poland (with first class honours, best in class) and then pursued her Ph.D. degree in the School of Pharmacy, Trinity College Dublin (completed in 2005). She holds a postgraduate diploma in quality improvement and completed "Research leaders" training. Lidia has published 76 high quality peer-review papers and contributed to numerous international conference presentations. Her current h-index is 25. She is also a co-inventor on a number of patent applications including "A method of producing porous microparticles" and "A polymeric nanoparticle". In addition to being an active researcher, she contributes to undergraduate (Pharmaceutics and Pharmaceutical Technology module) and postgraduate (Preformulation, Formulation and Advanced Drug Delivery modules) teaching. She is part of the coordinating team for the MSc in Pharmaceutical Sciences course. Lidia's research activities fit with national policy objectives supporting the development and production of a highly educated and relevant workforce in demand by the pharmaceutical industry. She and her team have successfully participated in collaborative, multidisciplinary and industry-led research consortia (IDDN, SSPC, H2020 RISE) leading to high impact research, leveraging international funding and attracting talented people to Ireland. The ultimate objective of her work is to advance the pharmaceutical product design and manufacture to benefit the general public and enhance the quality of health.
  Amorphous Materials   Computer modelling of pharmaceutical systems   Crystal engineering   DENDRIMERS   Drug Delivery Systems   Hydrogen bonding   LIQUID CRYSTALS   Nanotechnology   Pharmaceutical co-crystals   Pharmaceutical salts   Physical Chemistry   POLYMER   Polymers   POLYMORPHISM   Porous particles   Respiratory System   Spectroscopy   SPRAY DRYING   Thermal Analysis
 Synthesis and Solid State Pharmaceutical Centre
 TRANS-INT
 Solid State Pharmaceutical Cluster
 Active pharmaceutical ingredients as ionic liquids: significance of protonics and functional profiling for the design of effective medicines
 Irish Drug Delivery Network

Page 1 of 2
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
Polish Fluent Fluent Fluent
Russian Basic Basic Medium
Details Date From Date To
International Association for Pharmaceutical Technology (APV) 2017 present
American Chemical Society 2013 present
Controlled Release Society 2008 present
American Association of Pharmaceutical Scientists 2007 present
Knapik-Kowalczuk J, Gündüz MG, Chmiel K, Jurkiewicz K, Kurek M, Tajber L, Jachowicz R, Paluch M., Molecular dynamics, viscoelastic properties and physical stability studies of a new amorphous dihydropyridine derivative with T-type calcium channel blocking activity., European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 141, 2020, p105083 , Journal Article, PUBLISHED  DOI
McDonagh AF, Tajber L., Crystallo-co-spray drying as a new approach to manufacturing of drug/excipient agglomerates: impact of processing on the properties of paracetamol and lactose mixtures., International journal of pharmaceutics, 2020, p119051 , Journal Article, PUBLISHED  DOI
A.F. McDonagh, L. Tajber, The control of paracetamol particle size and surface morphology through crystallisation in a spray dryer, Advanced Powder Technology, 31, 2020, p287 - 299, Journal Article, PUBLISHED  DOI
Umerska A, Mugheirbi N, Kasprzak A, Saulnier P, Tajber L, Carbohydrate-based Trojan microparticles as carriers for pulmonary delivery of lipid nanocapsules using dry powder inhalation, Powder Technology, 2020, Journal Article, IN_PRESS  DOI
Nanoparticle Tracking Analysis to Examine the Temperature-Induced Aggregation of Proteins in, editor(s)McManus, J.J. , Protein Self-Assembly: Methods and Protocols , New York, Humana Press, 2019, pp131 - 139, [Sladek S., McComiskey K., Healy A.M., Tajber L.], Book Chapter, PUBLISHED  DOI
Wojnarowska Z, Tajber L, Paluch M, Density Scaling in Ionic Glass-Former Controlled by Grotthuss Conduction, Journal of Physical Chemistry B, 123, (5), 2019, p1156 - 1160, Journal Article, PUBLISHED  TARA - Full Text  DOI
Wojnarowska Z, Zotowa J, Knapik-Kowalczuk J, Tajber L, Paluch M, Effect of electrostatic interactions on the relaxation dynamics of pharmaceutical eutectics, European Journal of Pharmaceutical Sciences, 134, 2019, p93 - 101, Journal Article, PUBLISHED  TARA - Full Text  DOI
McComiskey KPM, McDonagh AF, Tajber L, Isolation of Itraconazole Nanostructured Microparticles via Spray Drying with Rational Selection of Optimum Base for Successful Reconstitution and Compaction, AAPS PharmSciTech, 20, (5), 2019, p217-, Journal Article, PUBLISHED  DOI
Mesallati H, Umerska A, Tajber L, Fluoroquinolone Amorphous Polymeric Salts and Dispersions for Veterinary Uses, Pharmaceutics, 11, (6), 2019, pE268-, Journal Article, PUBLISHED  DOI
Machado Cruz R, Santos-Martinez MJ, Tajber L., Impact of polyethylene glycol polymers on the physicochemical properties and mucoadhesivity of itraconazole nanoparticles., European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 144, 2019, p57 - 67, Journal Article, PUBLISHED  DOI
  

Page 1 of 22
Umerska A, Tajber L, Polyelectrolyte complexes as nanoparticulate drug delivery systems, European Pharmaceutical Review, 20, (3), 2015, p36-40 , Notes: [Invited review], Journal Article, PUBLISHED

  

Award Date
Trinity College Postgraduate Award 2001
Distinction for the Masters thesis in the Master's Degree Dissertations Competition for Faculties of Pharmacy organised by Polish Pharmaceutical Society and Medical Universities 2001
First prize for the Masters thesis in the Interdepartmental Master's Degree Dissertations Competition 2000
Prize from the Czestochowa branch of the Polish Pharmaceutical Chamber for the grades achieved in university degree 2000
M.A. (jure officii) 2015
My research programme concentrates on the fundamental understanding of molecular interactions governing the properties and performance of pharmaceutical substances (actives and additives) at molecular, supramolecular and formulation (drug product) levels. More specifically, the research topics pursued by my group are: . Advancement of the physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) by conversion into ionic liquids (anti-crystal engineering); development of oral solid formulations containing ionic liquids . Synthesis, phase characterisation and behaviour in formulation of alternative forms of APIs such as salts, cocrystals, amorphous materials, polymorphs and liquid crystals; construction of multi-phase diagrams for stability . Rational preformulation studies leading to quality solid-state formulations . Nanocrystal and polymeric nanoparticle formulation and characterisation methods My research efforts have been supported by Science Foundation Ireland (SFI), Enterprise Ireland, Irish Research Council as well as the European Union. I am involved in the Synthesis and Solid State Pharmaceuticals Centre (https://www.sspc.ie/ ) as a funded investigator. I was awarded a prestigious SFI Career Development Award in 2017 on the development of pharmaceutical ionic liquid forms and also currently serve as Director of Steering Committee in a H2020 RISE network "ORBIS" (Open Research Biopharmaceutical Internships Support (http://orbisproject.eu/ , awarded in 2017). I currently supervise a group of 8 researchers and host visiting ORBIS secondees from the pharmaceutical industry.